Ascletis Pharma Inc.

OTCPK:ASCL.F Stock Report

Market Cap: US$222.2m

Ascletis Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of ASCL.F?
Owner TypeNumber of SharesOwnership Percentage
Institutions12,336,0001.26%
General Public133,257,26313.6%
Private Companies209,672,01321.5%
Individual Insiders622,167,72463.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 14 shareholders own 86.37% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
52.8%
Jinzi Jason Wu
515,549,164US$117.2m0%no data
10.8%
Yang Dan
105,463,060US$24.0m0%no data
8.47%
Lakemont Holding Llc
82,827,414US$18.8m0%no data
6.41%
Jjw11 Limited
62,689,872US$14.3m0%no data
5.19%
CBC Investment Twelve Limited
50,729,518US$11.5m0%no data
1.37%
CBC Investment Fifteen Limited
13,425,209US$3.1m0%no data
0.34%
E Fund Management Co., Ltd.
3,285,000US$746.9k0%no data
0.28%
Dimensional Fund Advisors LP
2,691,000US$611.8k-28.8%no data
0.23%
JP Morgan Asset Management
2,265,000US$515.0k0%no data
0.19%
China Universal Asset Management Company Ltd.
1,818,000US$413.4k0%no data
0.16%
Fullgoal Fund Management Co. Ltd.
1,591,000US$361.7k0%no data
0.12%
Hejingdao Wu
1,155,500US$262.7k0%no data
0.051%
China Southern Asset Management Co., Ltd.
500,000US$113.7k0%no data
0.019%
American Century Investment Management Inc
186,000US$42.3k0%no data